Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2024 11:22 ET | Source: healthinsurance.org

Time for a checkup before kids head back to school

Minneapolis, MN, July 24, 2024 (GLOBE NEWSWIRE) -- With the beginning of the school year just around the corner, it’s time for kids to get their annual checkups. Today, healthinsurance.org explains...
July 24, 2024 10:00 ET | Source: Benevis

Benevis’ Porter Dental & Braces Selected for the Dental Assisting National Board’s Great Practice for Dental Assistants to Work Award

Atlanta, GA, July 24, 2024 (GLOBE NEWSWIRE) -- Benevis, a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, today...
July 24, 2024 09:56 ET | Source: Spherix Global Insights

Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Spherix Global Insights

EXTON, PA., June 20, 2024, July 24, 2024 (GLOBE NEWSWIRE) -- The American Society of Retinal Specialists (ASRS) annual meeting held last week in Stockholm, Sweden, showcased groundbreaking...
July 24, 2024 09:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Food Pathogen Testing Market Size is Expected to Grow $22.7 billion by 2028

Chicago, July 24, 2024 (GLOBE NEWSWIRE) -- The global food pathogen testing market is estimated to be valued at USD 15.1 Billion in 2023 and is projected to reach USD 22.7 Billion by 2028, at a CAGR...
July 24, 2024 09:00 ET | Source: Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program

PHOENIX, July 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial-stage biotechnology...
July 24, 2024 09:00 ET | Source: Helio Genomics

Helio Genomics to Participate in the 2024 UBS Genomic Medicine Summit

IRVINE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
July 24, 2024 08:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

DNA Diagnostics Market: $13.3B to $21.2B Growth Forecast (2024-2029) | MarketsandMarkets™

Chicago, July 24, 2024 (GLOBE NEWSWIRE) -- The "DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass...
July 24, 2024 08:30 ET | Source: PainReform Ltd

PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
July 24, 2024 08:30 ET | Source: Scorpius Holdings, Inc.

Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter

DURHAM, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization...
July 24, 2024 08:05 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...